Patents by Inventor Kazuki TAGUCHI

Kazuki TAGUCHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prostaglandin derivative
    Patent number: 10494338
    Abstract: The present invention relates to a novel prostaglandin derivative having an alkynyl group on ?-chain, particularly, a novel prostaglandin derivative having a double bond at the 2-position and an alkynyl group on the ?-chain and a medicament containing the compound as an active ingredient. According to the present invention, a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof; wherein each symbol is as defined in the present specification, or a cyclodextrin clathrate compound thereof, and a medicament containing the compound as an active ingredient, particularly, a medicament for the prophylaxis or treatment of a blood flow disorder associated with spinal canal stenosis or chronic arterial occlusion, can be provided.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: December 3, 2019
    Assignees: AGC INC., NIPPON ZOKI PHARMACEUTICAL CO., LTD.
    Inventors: Arata Yasuda, Yasushi Matsumura, Kazuyoshi Sawada, Hiroyoshi Nanba, Kazuki Taguchi
  • NOVEL PROSTAGLANDIN DERIVATIVE
    Publication number: 20190135743
    Abstract: The present invention relates to a novel prostaglandin derivative having an alkynyl group on ?-chain, particularly, a novel prostaglandin derivative having a double bond at the 2-position and an alkynyl group on the ?-chain and a medicament containing the compound as an active ingredient. According to the present invention, a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof; wherein each symbol is as defined in the present specification, or a cyclodextrin clathrate compound thereof, and a medicament containing the compound as an active ingredient, particularly, a medicament for the prophylaxis or treatment of a blood flow disorder associated with spinal canal stenosis or chronic arterial occlusion, can be provided.
    Type: Application
    Filed: May 9, 2017
    Publication date: May 9, 2019
    Applicants: AGC INC., NIPPON ZOKI PHARMACEUTICAL CO., LTD.
    Inventors: Arata YASUDA, Yasushi MATSUMURA, Kazuyoshi SAWADA, Hiroyoshi NANBA, Kazuki TAGUCHI